AEHR vs FISV
Aehr Test Systems vs Fiserv — AI-powered side-by-side comparison
AEHR
Aehr Test Systems
54
Watch
VS
| Metric | AEHR | FISV |
|---|
| AI Score |
54
|
69
|
| Price |
$117.30
|
$52.70
|
| P/E Ratio |
-509.48×
|
10.10×
|
| ROE |
-3.2%
|
13.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
34.7%
|
47.2%
|
| Debt / Equity |
0.04×
|
1.04×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
72.5
|
43.1
|
| Beta |
3.087
|
0.819
|
| Expected Upside |
—
|
+23.5%
|
AI Committee View
Current Innellis committee reasoning for AEHR versus FISV.
FISV leads by 15 points.
FISV scores 69/100 (Buy) versus AEHR at 54/100 (Watch).
AEHR Committee View
50% agreement
6 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Growth Analyst remains cautious — revenue declining -26.4% yoy -- this is not a growth story right now. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- ROE of only -8.9% -- cheap may mean cheap for a reason — Value
- Revenue declining -26.4% YoY -- this is not a growth story right now — Growth
- RSI at 72 is in overbought territory — Technical
FISV Committee View
75% agreement
4 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is macd histogram negative -- bearish momentum. The committee is constructive but not yet at full conviction.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- MACD histogram negative -- bearish momentum — Technical